Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
miércoles, 3 de julio de 2024
FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’ Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer's disease Melissa Rudy By Melissa Rudy Fox News Published July 2, 2024 5:04pm EDT
FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’
Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer's disease
Melissa Rudy By Melissa Rudy Fox News
Published July 2, 2024 5:04pm EDT
https://www.foxnews.com/health/fda-approves-new-drug-alzheimers-disease-meaningful-results
No hay comentarios:
Publicar un comentario